Mode of the autocrine/paracrine mechanism of growth hormone action

Experimental Cell Research

Volumn 237, Issue 1, 1997, Pages 196-206

  Liu, Niandong ^a   Mertani, Hichem C ^a   Norstedt, Gunnar ^b   Törnell, Jan ^c   Lobie, Peter E ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE ANTAGONIST; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE G120R; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CONTROLLED STUDY; DOSE RESPONSE; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031586603     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3789     Document Type: Article

References (45)

1. 1. Isaksson, O. G. P., Eden, S., and Jansson, J. O. (1985). Mode of action of pituitary growth hormone on target cells. Annu. Rev. Physiol. 47, 483-489.
2. 2. Kelly, P. A., Ali, S., Rozakis, M., Goujon, L., Nagano, M., Pelligrini, I., Gould, D., Djiane, J., Edery, M., and Finidori, J. (1993). The growth hormone/prolactin receptor family. Recent Prog. Horm. Res. 48, 123-164.
3. 3. Carter-Su, C., Schwartz, J., and Smit, L. S. (1996). Molecular mechanisms of growth hormone action. Annu. Rev. Physiol. 58, 187-207.
4. 4. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., and Silvennoinen, O. (1995). Signalling through the haemopoietic cytokine receptors. Annu. Rev. Immunol. 13, 369-398.
5. 5. Meyer, D. J., Campbell, G. S., Cochran, B. H., Argetsinger, L. S., Larner, A. C., Finbloom, D. S., and Carter-Su, C. (1994). Growth hormone induces a DNA binding factor related to interferon stimulated 91 KDa transcription factor. J. Biol. Chem. 269, 4701-4704.
6. 6. Campbell, G. S., Meyer, D. J., Raz, R., Levy, D. E., Schwartz, J., and Carter-Su, C. (1995). Activation of acute phase response factor (APRF)/STAT3 transcription factor by growth hormone. J. Biol. Chem. 270, 3974-3979.
7. 7. Sotiropoulos, A., Moutoussamy, S., Binart, N., and Kelly, P. A. (1995). The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of STAT3. FEBS Lett. 369, 169-172.
8. 8. Wood, T. J. J., Sliva, D., Lobie, P. E., Pircher, T. J., Gouilleux, F., Wakao, H., Gustafsson, J.-Å., Groner, B., Norstedt, G., and Haldosen, L.-A. (1995). Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/stat5. J. Biol. Chem. 270, 9448-9453.
9. 9. Waxman, D. J., Ram, P. A., Park, S. H., and Choi, H. K. (1995). Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver expressed, Stat5 related DNA binding protein. Proposed role as a regulator of male specific gene transcription. J. Biol. Chem. 270, 13262-13270.
10. 10. Bergard, P. L., Shih, H. M., Towle, H. C., Schwarzenberg, S. J., and Berry, S. A. (1995). Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a STAT5 related factor binding synergistically to two gamma activated sites. J. Biol. Chem. 270, 24903-24910.
11. 11. Sliva, D., Wood, T. J. J., Schindler, C., Lobie, P. E., and Norstedt, G. (1994). Growth hormone specifically regulates serine protease inhibitor gene transcription via gamma activated sequence-like DNA elements. J. Biol. Chem. 269, 26208-26214.
12. 12. Jansson, J.-O., Eden, S., and Isaksson, O. G. P. (1985). Sexual dimorphism in the control of growth hormone secretion. Endocrine Rev. 6, 128-150.
13. 13. Hojvat, S., Emanuele, N. V., Baker, G., Connick, E., Kirsteins, L., and Lawrence, A. M. (1982). Growth hormone, thyroid stimulating hormone and luteinizing hormone like peptides in the rodent brain: Non-parallel ontogenic development with pituitary counterparts. Dev. Brain Res. 4, 427-434.
14. 14. Gossard, F., Dihl, F., Pelletier, G., Dubois, P. M., and Morel, G. (1987). In situ hybridization to rat brain and pituitary gland of growth hormone cDNA. Neurosci. Lett. 79, 251-256.
15. 15. Mol, J. A., Van Garderen, E., Seman, P. J., Wolswinkel, J., Rijinberk, A., and Rutteman, G. R. (1995). Growth hormone mRNA in mammary gland tumours of dogs and cats. J. Clin. Invest. 95, 2028-2034.
16. 16. Mol, J. A., Van garderen, E., Rutteman, G. R., and Rijinberk, A. (1996). New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of GH in the mammary gland of dogs, cats and humans. J. Steroid Biochem. 57, 67-71.
17. 17. Wu, H., Devi, R., and Malarkey, W. B. (1996). Localization of the growth hormone messenger ribonucleic acid in the human immune system - a clinical research center study. J. Clin. Endo. Metab. 81, 1278-1282.
18. 18. Palmetshofer, A., Zechner, D., Luger, T. A., and Barta, A. (1995). Splicing variants of the human growth hormone mRNA - Detection in pituitary, mononuclear cells and dermal fibroblasts. Mol. Cell. Endocrinol. 113, 225-234.
19. 19. Maggiano, N., Piantelli, M., Ricci, R., Larocca, L. M., Capelli, A., and Raneletti, F. O. (1994). Detection of growth hormone producing cells in human thymus by immunocytochemistry and non-radioactive in situ hybridization. J. Histochem. Cytochem. 42, 1349-1354.
20. 20. Martin-Fontecha, A., Broekhuizen, R., De Heer, C., Zapat, A., and Schuurman, H. J. (1993). The neuroendocrine component of the rat thymus: Studies on cultured thymic fragments before and after transplantation in congenitally athymic and euthymic rats. Brain Behav. Immun. 7, 1-15.
21. 21. Weigent, D. A., and Blalock, J. E. (1991). The production of growth hormone by subpopulations of rat mononuclear leukocytes. Cell. Immunol. 135, 55-65.
22. 22. Scippo, M. L., Frankenne, F., Hooghe-Peters, E. L., Igout, A., Velkeniers, B., and Hennen, G. (1993). Syncitiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol. Cell. Endocrinol. 92, R7-R13.
23. 23. Hojvat, S., Emanuelle, N. V., Kirsteins, L., and Lawrence, A. M. (1986). Impact of endocrine manipulations on brain based growth hormone. Neuroendocrinology 44, 355-360.
24. 24. Weigent, D. A., Blalock, J. E., and LeBoeuf, R. D. (1991). An antisense oligonucleotide to growth hormone messenger riboucleic acid inhibits lymphocyte proliferation. Endocrinology 128, 2053-2057.
25. 25. Emtner, M., Mathews, L. S., and Norstedt, G. (1990). Growth hormone (GH) stimulates protein synthesis in cells transfected with GH receptor complementary DNA. Mol. Endocrinol. 4, 2014-2020.
26. 26. Palmiter, R. D., Norstedt, G., Gelinas, R. E., Hammer, R. E., and Brinster, R. L. (1983). Metallothionein-human GH fusion genes stimulate growth of mice. Science 222, 809-814.
27. 27. Goodwin, E. C., and Rottman, F. M. (1992). The 3′-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation. J. Biol. Chem. 267, 16330-16334.
28. 28. Francis, S. M., Enerback, S., Moller, C., Enberg, B., and Norstedt, G. (1993). A novel in vitro model for studying signal transduction via the growth hormone receptor. Mol. Endocrinol. 7, 972-978.
29. 29. Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V., and Wells, J. A. (1992). Rational design of potent antagonists to the human growth hormone receptor. Science 256, 1677-1680.
30. 30. Mode, A., Tollet, P., Wells, T., Carmignac, D. F., Clark, R. G., Chen, W. Y., Kopchick, J. J., and Robinson, I. C. (1996). The human growth hormone (hGH) antagonist G120RhGH does not antagonize GH in the rat but has paradoxical agonist activity, probably via the prolactin receptor. Endocrinology 137, 447-454.
31. 31. Selman, P. J., Mol, J. A., Rutteman, G. R., van Garderen, E., and Rijnberk, A. (1994). Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134, 287-292.
32. 32. Ezzat, S., Ezrin, C., Yamashita, S., and Melmed, S. (1993). Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumour. Cancer 71, 66-70.
33. 33. Harding, P. A., Wang, X., Okada, S., Chen, W. Y., Wan, W., and Kopchick, J. J. (1996). Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J. Biol. Chem. 271, 6708-6712.
34. 34. Lobie, P. E., Mertani, H., Morel, G., Morales-Bustos, O., Norstedt, G., and Waters, M. J. (1994). Receptor mediated nuclear translocation of growth hormone. J. Biol. Chem. 269, 21330-21339.
35. 35. Lobie, P. E., Wood, T. J. J., Chen, C. M., Waters, M. J., and Norstedt, G. (1994). Nuclear translocation and anchorage of the growth hormone receptor. J. Biol. Chem. 269, 31375-21746.
36. 36. Stout, L. E., Svensson, A. M., and Sorenson, R. L. (1997). Prolactin regulation of islet derived INS-1 cells: Characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 138, 1592-1603.
37. 37. Lobie, P. E., Ronsin, B., Silvennoinen, O., Haldosen, L. A., Norstedt, G., and Morel, G. (1996). Constitutive nuclear localization of Janus kinases 1 and 2. Endocrinology 137, 4037-4045.
38. 38. Wang, Y. F., and Yu-Lee, L. Y. (1996). Multiple stat complexes interact at the interferon regulatory factor-1 interferon gamma activation sequence in prolactin stimulated Nb2 T cells. Mol. Cell. Endocrinol. 121, 19-28.
39. 39. Dai, Z., Stiles, A. D., Moats-Staats, B., Van Wyk, J. J., and D'Ercole, A. J. (1992). Interaction of secreted insulin like growth factor-1 (IGF-1) with cell surface receptors is the dominant mechanism of IGF-1's autocrine actions. J. Biol. Chem. 267, 19565-19571.
40. 40. Hannon, K., Kudla, A. J., McAvoy, M. J., Glase, K. L., and Olwin, B. B. (1996). Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms. J. Cell Biol. 132, 1151-1159.
41. 41. Krown, K. A., Wang, Y. F., and Walker, A. M. (1994). Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line. Endocrinology 134, 1546-1552.
42. 42. Belchetz, P. E., Ridley, R. M., and Baker, H. F. (1982). Studies on the accessability of prolactin and growth hormone to brain. Brain Res. 239, 310-314.
43. 43. Lobie, P. E., Garcia-Aragon, J., Lincoln, D. T., Barnard, R., Wilcox, J. N., and Waters, M. J. (1993). Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Dev. Brain Res. 74, 225-233.
44. 44. Pantaleon, M., Harvey, M. B., Barnard, R. T., Waters, M. J., and Kaye, P. L. (1997). Functional GH receptors and GH mRNA are expressed by preimplantation mouse embryos: A role for GH in early embryogenesis? Proc. Natl. Acad. Sci. USA. [in press].
45. 45. Lobie, P. E., Garcia-Aragon, J., Wang, B. S., Baumbach, W. R., and Waters, M. J. (1992). Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130, 3057-3065.